help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kan, L.
Right arrow Articles by Kessler, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kan, L.
Right arrow Articles by Kessler, J. A.
(American Journal of Pathology. 2004;165:1107-1115.)
© 2004 American Society for Investigative Pathology

Transgenic Mice Overexpressing BMP4 Develop a Fibrodysplasia Ossificans Progressiva (FOP)-Like Phenotype

Lixin Kan*, Min Hu*, William A. Gomes{dagger} and John A. Kessler*

From the Department of Neurology,* Northwestern University Feinberg School of Medicine, Chicago, Illinois; and the Department of Neuroscience,{dagger} Albert Einstein College of Medicine, Bronx, New York

Fibrodysplasia ossificans progressiva (FOP) is a rare hereditary connective tissue disease characterized by progressive postnatal heterotopic bone formation. Although the genetic defects of FOP are not known, several lines of evidence have suggested that bone morphogenetic protein-4 (BMP4) may be involved in the pathophysiology. Nevertheless BMP4-transgenic mice have previously failed to develop the disorder and there has been no good animal model of the disease. Here, we report that a unique transgenic mouse line that overexpresses BMP4 under control of the neuron-specific enolase (NSE) promoter develops a FOP-like phenotype. Mating of these animals with transgenic animals that overexpress the BMP inhibitor noggin prevents the disorder, confirming the role of BMP4 in the pathogenesis of the disease. Heterotopic bone formation in these animals appears to follow the classic endochondral ossification pathway. Sex-mismatched cell transplantation experiments indicate that multiple cell sources contribute to the heterotopic ossification. This remarkable animal model provides a unique opportunity to further study the role of the BMP signaling pathway in heterotopic ossification and to improve our understanding of the clinical aspects of FOP.





This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
F. S. KAPLAN, J. GROPPE, R. J. PIGNOLO, and E. M. SHORE
Morphogen Receptor Genes and Metamorphogenes: Skeleton Keys to Metamorphosis
Ann. N.Y. Acad. Sci., November 1, 2007; 1116(1): 113 - 133.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
H. B. Yeon, F. S. Kaplan, E. M. Shore, A. E. Rosenberg, and J. B. Jupiter
Focal Fibronodular Heterotopic Ossification. A Case Report
J. Bone Joint Surg. Am., June 1, 2007; 89(6): 1329 - 1336.
[Full Text] [PDF]


Home page
JBJSHome page
F. S. Kaplan, D. L. Glaser, E. M. Shore, R. J. Pignolo, M. Xu, Y. Zhang, D. Senitzer, S. J. Forman, and S. G. Emerson
Hematopoietic Stem-Cell Contribution to Ectopic Skeletogenesis
J. Bone Joint Surg. Am., February 1, 2007; 89(2): 347 - 357.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
N. Y. Frank, A. T. Kho, T. Schatton, G. F. Murphy, M. J. Molloy, Q. Zhan, M. F. Ramoni, M. H. Frank, I. S. Kohane, and E. Gussoni
Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist Gremlin
J. Cell Biol., October 9, 2006; 175(1): 99 - 110.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
E. ABE
Function of BMPs and BMP Antagonists in Adult Bone
Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 41 - 53.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
F. S. KAPLAN, J. FIORI, L. S. DE LA PENA, J. AHN, P. C. BILLINGS, and E. M. SHORE
Dysregulation of the BMP-4 Signaling Pathway in Fibrodysplasia Ossificans Progressiva
Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 54 - 65.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. A. Kitterman, S. Kantanie, D. M. Rocke, and F. S. Kaplan
Iatrogenic Harm Caused by Diagnostic Errors in Fibrodysplasia Ossificans Progressiva
Pediatrics, November 1, 2005; 116(5): e654 - e661.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
M.F. Termaat, F.C. Den Boer, F.C. Bakker, P. Patka, and H.J.Th.M. Haarman
Bone Morphogenetic Proteins. Development and Clinical Efficacy in the Treatment of Fractures and Bone Defects
J. Bone Joint Surg. Am., June 1, 2005; 87(6): 1367 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G.D.M. Collett and A.E. Canfield
Angiogenesis and Pericytes in the Initiation of Ectopic Calcification
Circ. Res., May 13, 2005; 96(9): 930 - 938.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.